Apixaban in Atrial Fibrillation Registry

CArdioSurgEry Atrial Fibrillation Register

NCT03091452 ·Status: RECRUITING

A New Approach to Target the Substrates of Persistent Atrial Fibrillation: The Sequential Substrate Ablation Approach

NCT02654353 ·Status: COMPLETED ·Phase: PHASE4

A Prospective Study to Examine the Need to Adjust the Dose of Apixaban When Used in Atrial Fibrillation and Obesity

NCT03893591 ·Status: COMPLETED

Relationship Between Renal Function and Pharmacokinetics of Apixaban and Clinical Outcome of Apixaban in Thai Non-valvular Atrial Fibrillation Patients

NCT04684732 ·Status: UNKNOWN

ABLATOR Ablation Observational Registry

NCT02344173 ·Status: COMPLETED

An Observational Study (Called RETAF-PS) Using a Patient Survey to Learn More About Treatment Outcomes in Patients With Irregular and Often Rapid Heartbeat (Atrial Fibrillation) Treated With Apixaban in a Real World Setting

NCT05471830 ·Status: COMPLETED

Global Anticoagulant Registry in the Field

NCT01090362 ·Status: COMPLETED

Local Adaptation of Cost Effectiveness Model for Apixaban Atrial Fibrillation Indication - Venezuela

NCT02756481 ·Status: COMPLETED

Atrial Fibrillation Incidence, Risk Factors and Genetics

NCT00021905 ·Status: COMPLETED

Atrial Fibrillation in Relationship to Plasma Biomarkers

NCT04710745 ·Status: UNKNOWN

Atrial Fibrillation Registry 2017

NCT05023590 ·Status: UNKNOWN ·Phase: NA

BLITZ Atrial Fibrillation

NCT03653598 ·Status: COMPLETED

Safety and Effectiveness of Apixaban Compared to Warfarin in Patients With Non-valvular Atrial Fibrillation (a Type of Irregular Heart Rhythm) at Higher Chance of Bleeding

NCT05471505 ·Status: COMPLETED

Biomarkers in Patients Undergoing Atrial Fibrillation Ablation

NCT03388333 ·Status: COMPLETED

GENERAL;GENeral Practitioners and Embolism pRevention in NVAF Patients Treated With RivAroxaban:reaL-life Evidence

NCT02633982 ·Status: UNKNOWN

Atrial Fibrillation General Registry

NCT02518984 ·Status: COMPLETED

Atrial Fibrillation Research Database

NCT03760874 ·Status: UNKNOWN

Apixaban Drug Utilization Study In Stroke Prevention In Atrial Fibrillation (Spaf)

NCT03441633 ·Status: COMPLETED

Multidisciplinary Team Approach to Prescribe Antithrombotic Therapy in Older People With Atrial Fibrillation

NCT04932603 ·Status: COMPLETED

Supporting Use of AC Through Provider Profiling of Oral AC Therapy for AF

NCT03583008 ·Status: COMPLETED ·Phase: NA

Prospective Registration and Assessment of Serious Adverse Events Within the AFNET

NCT01678456 ·Status: COMPLETED

International Registry on Cardioversion of Atrial Fibrillation (MK-6621-051)

NCT01119716 ·Status: COMPLETED

Treatment and Outcomes of Atrial Fibrillation and Acute Coronary Syndrome in Sweden

NCT03311139 ·Status: COMPLETED

Study to Investigate the Effect of the A1 Agonist Capadenoson on Ventricular HR in Patients With Persistent or Permanent Atrial Fibrillation.

NCT00568945 ·Status: COMPLETED ·Phase: PHASE2

Study to Learn More About the Benefits and Side-effects of Drugs Rivaroxaban and Apixaban Compared to the Drug Warfarin for Stroke Prevention in Patients With Rapid and Irregular Heartbeat Which is Not Due to a Heart-valve Fault (Non-valvular Atrial Fibrillation) in the UK Routine Clinical Practice

NCT03847181 ·Status: COMPLETED